0001104659-20-133848.txt : 20201209 0001104659-20-133848.hdr.sgml : 20201209 20201209204925 ACCESSION NUMBER: 0001104659-20-133848 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201208 FILED AS OF DATE: 20201209 DATE AS OF CHANGE: 20201209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rolph Timothy CENTRAL INDEX KEY: 0001779479 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 201379191 MAIL ADDRESS: STREET 1: C/O AKERO THERAPEUTICS, INC. STREET 2: 170 HARBOR WAY, 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 tm2038113d2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2020-12-08 0 0001744659 Akero Therapeutics, Inc. AKRO 0001779479 Rolph Timothy C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Scientific Officer Common Stock 2020-06-30 5 A 0 E 1245 17.068 A 244178 D Stock Option (Right to Buy) 28.35 2020-12-08 4 A 0 77580 0 A 2030-12-07 Common Stock 77580 77580 D These shares were acquired on June 30, 2020 pursuant to the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). This option shall vest and become exercisable in 48 equal monthly installments, commencing on December 8, 2020. /s/ Jonathan Young, Attorney-in-fact 2020-12-09